Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

Estracyt

National Institutes of Health

Related topics

Related topics

4 relations
Emcyt

Broader (3)

EstramustineEstramustine Phosphate SodiumEstramustine phosphate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1983
Highly Cited
1983
Treatment of newly diagnosed metastatic prostate cancer patients with chemotherapy agents in combination with hormones versus hormones alone
A prospective trial from July 1976 to September 1980 by the National Prostatic Cancer Project randomized newly diagnosed… 
Review
1983
Review
1983
Guide-lines in the design of new antiestrogens and cytotoxic-linked estrogens for the treatment of breast cancer.
1981
1981
Plasma concentrations of estramustine phosphate and its major metabolites in patients with prostatic carcinoma treated with different doses of estramustine phosphate (Estracyt).
Plasma concentrations of estramustine phosphate and its major metabolites were measured in patients with prostatic carcinoma… 
Highly Cited
1980
Highly Cited
1980
Cardiovascular complications to treatment of prostate cancer with estramustine phosphate (Estracyt) or conventional estrogen. A follow-up of 212 randomized patients.
Two hundred and twelve patients treated for prostatic cancer grade I or II were investigated for cardiovascular complications… 
1980
1980
Estracyt therapy of advanced prostatic cancer with special reference to control of therapy with cytology and DNA cytophotometry.
81 patients with advanced prostate carcinoma, mainly estrogen resistant, were treated with Estracyt. After a pilot study had… 
Highly Cited
1979
Highly Cited
1979
Steroid receptor content in human prostatic carcinoma and response to endocrine therapy
Biopsy material from primary prostatic carcinoma from 25 patients was analyzed with regard to cytosol content of methyltrienolone… 
Highly Cited
1977
Highly Cited
1977
Treatment of advanced prostatic carcinoma with estramustine phosphate (Estracyt).
Estramustine phosphate (Estracyt) was used in the treatment of 154 patients with carcinoma of the prostate in stage IV. Sixty… 
1976
1976
The absorption metabolism, and excretion of Estracyt (NSC 89199) in patients with prostatic cancer.
Estraumustine phosphate (estradiol, 3-N-[bis(2-chloroethyl)-] carbamate-17beta-dihydrogenphosphate (Estracyt) labeled with 3H in… 
1974
1974
Studies on the antiprostatic action of estracyt, a nitrogen mustard of estradiol.
SUMMARY Estracyt, a chemical ester of a nitrogen mustard with estradiol-17/3, was tested for its antiprostatic effects in dogs… 
  • table 2
  • table I
  • table 2
Highly Cited
1971
Highly Cited
1971
Treatment of advanced prostatic carcinoma with Estracyt. A preliminary report.
Sixty-five patients with advanced prostatic carcinoma that had not responded to conventional therapy were treated with Estracyt… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE